BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 3669658)

  • 1. Antiprogesterone and antiglucocorticoid actions of RU 486 on rabbit mammary gland explant cultures. Evidence for a persistent inhibitory action of residual progesterone upon the mammary tissue.
    Jahn GA; Houdebine LM; Djiane J
    J Steroid Biochem; 1987 Oct; 28(4):371-7. PubMed ID: 3669658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of progesterone, promegestone and RU 486 on glucocorticoid receptor levels in primary cultures of mouse mammary epithelial cells.
    Schneider W; Gauthier Y; Shyamala G
    J Steroid Biochem; 1988 Jun; 29(6):599-604. PubMed ID: 3386227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of casein synthesis by progestagens in vitro: modulation in relation to concentration of hormones that synergize with prolactin.
    Jahn GA; Djiane J; Houdebine LM
    J Steroid Biochem; 1989 Mar; 32(3):373-9. PubMed ID: 2649745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding and action of glucocorticoids and mineralocorticoids in rabbit mammary gland. Exclusive participation of glucocorticoid type II receptors for stimulation of casein synthesis.
    Jahn GA; Moguilewsky M; Houdebine LM; Djiane J
    Mol Cell Endocrinol; 1987 Aug; 52(3):205-12. PubMed ID: 3653504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolactin release-inhibitory effects of progesterone, megestrol acetate, and mifepristone (RU 38486) by cultured rat pituitary tumor cells.
    Lamberts SW; van Koetsveld P; Verleun T
    Cancer Res; 1987 Jul; 47(14):3667-71. PubMed ID: 3594432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of the anti-progestin RU-486 to rat ovary steroid receptors.
    Schreiber JR; Hsueh AJ; Baulieu EE
    Contraception; 1983 Jul; 28(1):77-85. PubMed ID: 6627946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortisol 21-mesylate exerts glucocorticoid action on the induction of milk protein synthesis in cultured mammary gland.
    Terada N; Oka T
    Horm Metab Res; 1983 Oct; 15(10):508-12. PubMed ID: 6357980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RU 38486: potent antiglucocorticoid activity correlated with strong binding to the cytosolic glucocorticoid receptor followed by an impaired activation.
    Moguilewsky M; Philibert D
    J Steroid Biochem; 1984 Jan; 20(1):271-6. PubMed ID: 6708512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progesterone receptor directly inhibits β-casein gene transcription in mammary epithelial cells through promoting promoter and enhancer repressive chromatin modifications.
    Buser AC; Obr AE; Kabotyanski EB; Grimm SL; Rosen JM; Edwards DP
    Mol Endocrinol; 2011 Jun; 25(6):955-68. PubMed ID: 21527503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Binding characteristics of RU 486 with glucocorticoid and progestin receptors].
    Fukuoka H; Jimbo T
    Nihon Naibunpi Gakkai Zasshi; 1988 Aug; 64(8):698-706. PubMed ID: 3224726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progesterone receptor repression of prolactin/signal transducer and activator of transcription 5-mediated transcription of the beta-casein gene in mammary epithelial cells.
    Buser AC; Gass-Handel EK; Wyszomierski SL; Doppler W; Leonhardt SA; Schaack J; Rosen JM; Watkin H; Anderson SM; Edwards DP
    Mol Endocrinol; 2007 Jan; 21(1):106-25. PubMed ID: 16973758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antiglucocorticoid and antiprogestin steroid RU 486 suppresses the adrenocorticotropin response to ovine corticotropin releasing hormone in man.
    Laue L; Chrousos GP; Loriaux DL; Barnes K; Munson P; Nieman L; Schaison G
    J Clin Endocrinol Metab; 1988 Feb; 66(2):290-3. PubMed ID: 2828406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RU 38486: a potent antiglucocorticoid in vitro and in vivo.
    Gagne D; Pons M; Philibert D
    J Steroid Biochem; 1985 Sep; 23(3):247-51. PubMed ID: 2864478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occurrence of common binding sites for progestin and glucocorticoid in the lactating mammary gland of the rat.
    Maki M; Hirose M; Chiba H
    J Biochem; 1980 Dec; 88(6):1845-54. PubMed ID: 7193205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the relation between receptor binding affinity and antagonist efficacy of antiglucocorticoids.
    Gagne D; Pons M; Crastes de Paulet A
    J Steroid Biochem; 1986 Sep; 25(3):315-22. PubMed ID: 2877119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma concentrations and receptor binding of RU 486 and its metabolites in humans.
    Heikinheimo O; Kontula K; Croxatto H; Spitz I; Luukkainen T; Lähteenmäki P
    J Steroid Biochem; 1987 Feb; 26(2):279-84. PubMed ID: 3560943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Administration of RU 486 for 8 days in normal volunteers: antiglucocorticoid effect with no evidence of peripheral cortisol deprivation.
    Bertagna X; Escourolle H; Pinquier JL; Coste J; Raux-Demay MC; Perles P; Silvestre L; Luton JP; Strauch G
    J Clin Endocrinol Metab; 1994 Feb; 78(2):375-80. PubMed ID: 8106625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linoleic acid, but not cortisol, stimulates accumulation of casein by mouse mammary epithelial cells in serum-free collagen gel culture.
    Levay-Young BK; Bandyopadhyay GK; Nandi S
    Proc Natl Acad Sci U S A; 1987 Dec; 84(23):8448-52. PubMed ID: 3317407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tonic support of luteinizing hormone secretion by adrenal progesterone in the ovariectomized monkey replaced with midfollicular phase levels of estradiol.
    Xiao E; Xia-Zhang L; Shanen D; Ferin M
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2233-8. PubMed ID: 9215299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of steroid hormones and antihormones in cultured cells.
    Jung-Testas I; Baulieu EE
    Exp Clin Endocrinol; 1985 Dec; 86(2):151-64. PubMed ID: 2936615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.